Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATT...

por Nekvindová, Lucie, Vencovský, Jiří, Pavelka, Karel, Horák, Pavel, Křístková, Zlatuše, Závada, Jakub
Publicado 2021

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA

por Milota, Tomas, Hurnakova, Jana, Pavelka, Karel, Kristkova, Zlatuse, Nekvindova, Lucie, Horvath, Rudolf
Publicado 2022

The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry

por Skácelová, Martina, Nekvindová, Lucie, Mann, Heřman, Závada, Jakub, Křístková, Zlatuše, Vencovský, Jiří, Pavelka, Karel, Horák, Pavel
Publicado 2022

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSp...

por Lindström, Ulf, Di Giuseppe, Daniela, Delcoigne, Bénédicte, Glintborg, Bente, Möller, Burkhard, Ciurea, Adrian, Pombo-Suarez, Manuel, Sanchez-Piedra, Carlos, Eklund, Kari, Relas, Heikki, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Jones, Gareth T, Codreanu, Catalin, Ionescu, Ruxandra, Nekvindova, Lucie, Závada, Jakub, Atas, Nuh, Yolbas, Servet, Fagerli, Karen Minde, Michelsen, Brigitte, Rotar, Žiga, Tomšič, Matija, Iannone, Florenzo, Santos, Maria Jose, Avila-Ribeiro, Pedro, Ørnbjerg, Lykke Midtbøll, Østergaard, Mikkel, Jacobsson, Lennart TH, Askling, Johan, Nissen, Michael J
Publicado 2021